Cross-β structure comprising amyloid-binding proteins and methods for detection of the cross-β structure, for modulating cross-β structures fiber formation and modulating cross-β structure-mediated toxicity
AssigneeCrossbeta Biosciences B.V.
InventorsBarend Bouma, Martin F. B. G. Gebbink, Onno W. Kranenburg, Louise M. J. Kroon-Batenburg
Life of this patent
Estimating the term…
Abstract
The invention relates to the field of biochemistry, molecular biology, structural biology and medicine. More in particular, the invention relates to cross-β structures and the biological role of these cross-β structures. In one embodiment, the invention discloses a method for modulating extracellular protein degradation and/or protein clearance comprising modulating cross-β(beta) structure formation (and/or cross-β structure-mediated activity) of the protein present in the circulation.
Claims1
A method for diminishing plaques comprising cross-β structures involved in a disease in a subject, the method comprising administering, to a subject in need thereof, a compound able to directly bind to a cross-β structure in a protein in the subject, for the purpose of allowing the subject to remove the cross-β structure, so as to diminish plaques in the subject, wherein said compound is a peptide consisting of a finger domain.
Dependencies are inferred from the claim text.